Finally, most patients were not prescribed novel heart failure drugs, such as an ARNI or SGLT2 inhibitors, further studies are needed to evaluate the effect of these medications on the ventricular arrhythmia events in CRT patients. This evidence concerns the gene SLC5A2 and heart failure.